title: Chimeric antigen receptor-engineered T cells for immunotherapy of cancer.
abstract: CD4+ and CD8+ T lymphocytes are powerful components of adaptive immunity, which essentially contribute to the elimination of tumors. Due to their cytotoxic capacity, T cells emerged as attractive candidates for specific immunotherapy of cancer. A promising approach is the genetic modification of T cells with chimeric antigen receptors (CARs). First generation CARs consist of a binding moiety specifically recognizing a tumor cell surface antigen and a lymphocyte activating signaling chain. The CAR-mediated recognition induces cytokine production and tumor-directed cytotoxicity of T cells. Second and third generation CARs include signal sequences from various costimulatory molecules resulting in enhanced T-cell persistence and sustained antitumor reaction. Clinical trials revealed that the adoptive transfer of T cells engineered with first generation CARs represents a feasible concept for the induction of clinical responses in some tumor patients. However, further improvement is required, which may be achieved by second or third generation CAR-engrafted T cells.
authors.affiliation: Institute of Immunology, Medical Faculty, Technical University of Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.
authors.forename: Marc
authors.initials: M
authors.lastname: Cartellieri
authors.forename: Michael
authors.initials: M
authors.lastname: Bachmann
authors.forename: Anja
authors.initials: A
authors.lastname: Feldmann
authors.forename: Claudia
authors.initials: C
authors.lastname: Bippes
authors.forename: Slava
authors.initials: S
authors.lastname: Stamova
authors.forename: Rebekka
authors.initials: R
authors.lastname: Wehner
authors.forename: Achim
authors.initials: A
authors.lastname: Temme
authors.forename: Marc
authors.initials: M
authors.lastname: Schmitz
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D051379:Mice; D018448:Models, Immunological; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D015202:Protein Engineering / Q000379:methods*; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism / Q000627:therapeutic use*; D015398:Signal Transduction / Q000276:immunology
chemical_list: D000951:Antigens, Neoplasm; D011948:Receptors, Antigen, T-Cell; D011993:Recombinant Fusion Proteins
references.citation: Blood. 2000 Aug 1;96(3):785-93
references.pmid: 10910888
references.citation: Nat Rev Immunol. 2006 Apr;6(4):295-307
references.pmid: 16557261
references.citation: Blood. 2002 Nov 1;100(9):3155-63
references.pmid: 12384413
references.citation: Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9571-6
references.pmid: 15980149
references.citation: J Immunother. 2007 Oct;30(7):684-93
references.pmid: 17893561
references.citation: Cancer Immunol Immunother. 2009 May;58(5):809-22
references.pmid: 19189103
references.citation: Nat Rev Cancer. 2003 Jan;3(1):35-45
references.pmid: 12509765
references.citation: J Clin Invest. 2005 Jun;115(6):1616-26
references.pmid: 15931392
references.citation: Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8905-9
references.pmid: 1833767
references.citation: J Immunol. 2002 Nov 15;169(10):5780-6
references.pmid: 12421958
references.citation: Blood. 2005 Sep 1;106(5):1544-51
references.pmid: 15890688
references.citation: J Immunol. 2006 Oct 15;177(8):5668-75
references.pmid: 17015756
references.citation: J Immunol. 2004 Dec 15;173(12):7647-53
references.pmid: 15585893
references.citation: Gene Ther. 2000 Jan;7(1):35-42
references.pmid: 10680014
references.citation: Cancer Res. 2006 Nov 15;66(22):10995-1004
references.pmid: 17108138
references.citation: Nat Med. 2007 Dec;13(12):1440-9
references.pmid: 18026115
references.citation: Cancer Res. 2004 Dec 15;64(24):9160-6
references.pmid: 15604287
references.citation: Prostate. 2004 Sep 15;61(1):12-25
references.pmid: 15287090
references.citation: Biochem Biophys Res Commun. 1987 Dec 31;149(3):960-8
references.pmid: 3122749
references.citation: Nat Med. 2008 Nov;14(11):1264-70
references.pmid: 18978797
references.citation: Mol Ther. 2009 Aug;17(8):1453-64
references.pmid: 19384291
references.citation: Nat Rev Immunol. 2009 Apr;9(4):271-85
references.pmid: 19319144
references.citation: Blood. 2002 Mar 15;99(6):2009-16
references.pmid: 11877273
references.citation: Biomol Eng. 2007 Oct;24(4):361-73
references.pmid: 17409021
references.citation: Cytotherapy. 2006;8(2):105-17
references.pmid: 16698684
references.citation: J Immunol. 2008 Jan 1;180(1):72-8
references.pmid: 18097006
references.citation: Curr Opin Immunol. 2009 Apr;21(2):215-23
references.pmid: 19327974
references.citation: J Immunother. 2005 May-Jun;28(3):203-11
references.pmid: 15838376
references.citation: Nature. 1999 Oct 14;401(6754):708-12
references.pmid: 10537110
references.citation: Cancer Res. 2007 Nov 15;67(22):11029-36
references.pmid: 18006849
references.citation: Nat Med. 2003 Mar;9(3):279-86
references.pmid: 12579196
references.citation: J Immunol. 1996 Jul 15;157(2):836-43
references.pmid: 8752936
references.citation: Cancer Res. 2007 Jan 1;67(1):5-8
references.pmid: 17210676
references.citation: Int J Mol Med. 1998 Jul;2(1):99-103
references.pmid: 9854151
references.citation: Cancer Res. 2005 Oct 1;65(19):9080-8
references.pmid: 16204083
references.citation: Nat Med. 1998 Feb;4(2):168-72
references.pmid: 9461189
references.citation: Immunity. 2008 Dec 19;29(6):848-62
references.pmid: 19100699
references.citation: Expert Opin Biol Ther. 2009 Jun;9(6):725-36
references.pmid: 19456207
references.citation: Annu Rev Immunol. 2007;25:243-65
references.pmid: 17129181
references.citation: Eur J Immunol. 1996 Oct;26(10):2304-9
references.pmid: 8898938
references.citation: Cancer Immunol Immunother. 2007 Dec;56(12):1875-83
references.pmid: 17479266
references.citation: Curr Opin Immunol. 2009 Apr;21(2):167-72
references.pmid: 19282163
references.citation: Cancer. 2007 Jan 15;109(2):170-9
references.pmid: 17154393
references.citation: Gene Ther. 1995 Oct;2(8):539-46
references.pmid: 8593604
references.citation: Eur J Immunol. 2009 Aug;39(8):2088-94
references.pmid: 19637200
references.citation: Proc Natl Acad Sci U S A. 1989 Dec;86(24):10024-8
references.pmid: 2513569
references.citation: Nat Biotechnol. 2002 Jan;20(1):70-5
references.pmid: 11753365
references.citation: Nat Rev Cancer. 2008 Apr;8(4):299-308
references.pmid: 18354418
references.citation: Cancer Immunol Immunother. 2002 Oct;51(8):417-23
references.pmid: 12202902
references.citation: Blood. 2008 Sep 15;112(6):2261-71
references.pmid: 18509084
references.citation: Annu Rev Immunol. 2009;27:591-619
references.pmid: 19132916
references.citation: Blood. 2007 Oct 15;110(8):2793-802
references.pmid: 17638856
references.citation: J Immunol. 2007 Oct 1;179(7):4910-8
references.pmid: 17878391
references.citation: Bone Marrow Transplant. 2008 Jan;41(2):193-8
references.pmid: 17982497
references.citation: Cancer Gene Ther. 2000 Jan;7(1):128-34
references.pmid: 10678365
references.citation: Br J Haematol. 2004 Aug;126(4):583-92
references.pmid: 15287953
references.citation: J Clin Invest. 2007 Jun;117(6):1466-76
references.pmid: 17549249
references.citation: Neoplasia. 1999 Jun;1(2):123-7
references.pmid: 10933046
references.citation: J Immunol. 2009 Nov 1;183(9):5563-74
references.pmid: 19843940
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3360-5
references.pmid: 19211796
references.citation: J Immunol. 2007 Apr 1;178(7):4650-7
references.pmid: 17372024
references.citation: J Immunol. 1997 Dec 1;159(11):5509-15
references.pmid: 9548491
references.citation: J Clin Invest. 2004 Dec;114(12):1774-81
references.pmid: 15599402
references.citation: Trends Immunol. 2001 May;22(5):269-76
references.pmid: 11323286
references.citation: J Pediatr Hematol Oncol. 2007 Oct;29(10):669-77
references.pmid: 17921847
references.citation: Cancer Res. 1995 Aug 1;55(15):3369-73
references.pmid: 7614473
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19051-6
references.pmid: 16365285
references.citation: J Exp Med. 1998 Aug 17;188(4):619-26
references.pmid: 9705944
references.citation: Leukemia. 2006 Oct;20(10):1819-28
references.pmid: 16932339
references.citation: J Immunotoxicol. 2008 Oct;5(4):361-7
references.pmid: 19404870
references.citation: Gene Ther. 1999 Feb;6(2):300-4
references.pmid: 10435115
references.citation: Cytotherapy. 2003;5(2):131-8
references.pmid: 12745575
references.citation: J Immunol. 2004 Jan 1;172(1):104-13
references.pmid: 14688315
references.citation: Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):131-6
references.pmid: 9435856
references.citation: Annu Rev Immunol. 2005;23:515-48
references.pmid: 15771580
references.citation: J Exp Med. 1993 Apr 1;177(4):1093-103
references.pmid: 8459204
references.citation: Cell. 1989 Sep 8;58(5):911-21
references.pmid: 2528411
references.citation: Blood. 2000 Sep 1;96(5):1999-2001
references.pmid: 10961908
references.citation: Cancer Res. 2007 Mar 1;67(5):2265-73
references.pmid: 17332357
references.citation: Cancer Immunol Immunother. 2009 May;58(5):801-8
references.pmid: 19089424
references.citation: Mol Ther. 2009 May;17(5):880-8
references.pmid: 19259067
references.citation: J Clin Invest. 2008 Jan;118(1):294-305
references.pmid: 18060041
references.citation: Trends Pharmacol Sci. 2008 Aug;29(8):383-90
references.pmid: 18599129
references.citation: J Immunol. 1998 Sep 15;161(6):2791-7
references.pmid: 9743337
references.citation: Eur J Immunol. 1998 May;28(5):1663-72
references.pmid: 9603473
references.citation: J Clin Invest. 2007 May;117(5):1204-12
references.pmid: 17476350
references.citation: Cancer Res. 2001 Mar 1;61(5):1976-82
references.pmid: 11280755
references.citation: Mol Ther. 2005 Nov;12(5):933-41
references.pmid: 15979412
references.citation: Cancer Res. 2008 Apr 15;68(8):2961-71
references.pmid: 18413766
references.citation: J Immunother. 2009 Apr;32(3):310-21
references.pmid: 19242369
references.citation: Gene Ther. 2009 May;16(5):596-604
references.pmid: 19158846
references.citation: Blood. 2006 Dec 1;108(12):3890-7
references.pmid: 16926291
references.citation: Nat Rev Immunol. 2006 Aug;6(8):618-23
references.pmid: 16868553
references.citation: Springer Semin Immunopathol. 1996;18(2):199-209
references.pmid: 8908700
references.citation: Curr Opin Immunol. 2009 Apr;21(2):233-40
references.pmid: 19304471
references.citation: Hum Gene Ther. 2007 Aug;18(8):712-25
references.pmid: 17685852
references.citation: J Immunother. 2006 Jan-Feb;29(1):21-31
references.pmid: 16365597
references.citation: Gene Ther. 2009 Sep;16(9):1088-96
references.pmid: 19554034
references.citation: Blood. 1994 Nov 1;84(9):2878-89
references.pmid: 7949163
references.citation: Annu Rev Immunol. 2007;25:267-96
references.pmid: 17134371
references.citation: Gene Ther. 1999 Mar;6(3):412-9
references.pmid: 10435091
references.citation: Blood. 2001 Oct 15;98(8):2364-71
references.pmid: 11588032
references.citation: Adv Immunol. 1998;68:257-69
references.pmid: 9505091
references.citation: Proc Natl Acad Sci U S A. 2002 May 14;99(10):7009-14
references.pmid: 11997459
references.citation: Hum Gene Ther. 2000 Nov 20;11(17):2377-87
references.pmid: 11096442
references.citation: Blood. 2006 Apr 1;107(7):2643-52
references.pmid: 16352804
references.citation: Nature. 2001 May 17;411(6835):380-4
references.pmid: 11357146
references.citation: Mol Ther. 2007 Apr;15(4):825-33
references.pmid: 17299405
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5784-8
references.pmid: 19307587
references.citation: J Immunother. 2009 Apr;32(3):292-301
references.pmid: 19242371
references.citation: Immunol Rev. 1996 Oct;153:47-83
references.pmid: 9010719
references.citation: Hum Gene Ther. 1999 Mar 1;10(4):559-63
references.pmid: 10094199
references.citation: J Immunol Methods. 2001 Feb 1;248(1-2):67-76
references.pmid: 11223069
references.citation: J Immunol. 2000 Apr 1;164(7):3705-12
references.pmid: 10725729
references.citation: Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):720-4
references.pmid: 8421711
references.citation: Blood. 2005 Apr 15;105(8):3087-93
references.pmid: 15626734
references.citation: J Hematother Stem Cell Res. 2002 Dec;11(6):929-40
references.pmid: 12590708
references.citation: Gastroenterology. 2009 May;136(5):1721-31
references.pmid: 19208357
references.citation: Blood. 2007 Oct 1;110(7):2620-30
references.pmid: 17507664
references.citation: J Immunother. 2000 Nov-Dec;23(6):631-42
references.pmid: 11186151
references.citation: Cancer Res. 2003 May 15;63(10):2470-6
references.pmid: 12750268
references.citation: Blood. 2009 Jun 18;113(25):6392-402
references.pmid: 19377047
references.citation: Crit Rev Immunol. 2009;29(3):187-201
references.pmid: 19538134
references.citation: Cancer Res. 2007 Sep 1;67(17):8335-43
references.pmid: 17804749
references.citation: J Immunol. 2002 Aug 15;169(4):1753-9
references.pmid: 12165496
references.citation: J Immunol. 2001 Jul 15;167(2):1090-6
references.pmid: 11441120
references.citation: Gastroenterology. 2008 Jun;134(7):2014-24
references.pmid: 18424268
references.citation: Blood. 2003 Feb 15;101(4):1637-44
references.pmid: 12393484
references.citation: Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17469-74
references.pmid: 19805141
references.citation: Cancer Immunol Immunother. 2007 May;56(5):731-7
references.pmid: 17143613
references.citation: J Clin Oncol. 2006 May 1;24(13):e20-2
references.pmid: 16648493
references.citation: Curr Opin Immunol. 2009 Apr;21(2):200-8
references.pmid: 19285848
references.citation: J Immunol. 2001 Dec 1;167(11):6123-31
references.pmid: 11714771
references.citation: J Immunol. 2001 Jan 1;166(1):182-7
references.pmid: 11123291
references.citation: Cancer Gene Ther. 2007 Jan;14(1):91-7
references.pmid: 17024231
references.citation: Hum Gene Ther. 2010 Apr;21(4):427-37
references.pmid: 19905893
references.citation: Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6106-15
references.pmid: 17062687
references.citation: Int J Cancer. 1998 Jul 17;77(2):181-7
references.pmid: 9650549
references.citation: Cancer Gene Ther. 1998 Nov-Dec;5(6):401-7
references.pmid: 9917095
references.citation: J Immunol. 2008 May 15;180(10):7028-38
references.pmid: 18453625
references.citation: Gene Ther. 2003 Aug;10(17):1408-19
references.pmid: 12900755
references.citation: Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6879-84
references.pmid: 10359807
references.citation: Mol Ther. 2008 Mar;16(3):580-9
references.pmid: 18227839
references.citation: Blood. 2005 Nov 1;106(9):2995-3003
references.pmid: 16030195
references.citation: J Immunol. 2008 Apr 1;180(7):4901-9
references.pmid: 18354214
references.citation: Curr Opin Immunol. 2009 Apr;21(2):209-14
references.pmid: 19321326
references.citation: Prostate. 2007 Jul 1;67(10):1121-31
references.pmid: 17492652
references.citation: Cancer Res. 2007 Jun 15;67(12):5957-64
references.pmid: 17575166
references.citation: Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5426-35
references.pmid: 17855649
references.citation: Blood. 2003 Jul 15;102(2):497-505
references.pmid: 12649146